NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Genomics & Genetics Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Genomics & Genetics Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Alzheimer Disease



Data on Alzheimer disease detailed by researchers at Technical University of Munich



June 19th, 2009

In this recent study, researchers in Munich, Germany conducted a study "To examine the influence of the APOE genotype on levels of beta-amyloid (A beta) plaque load and atrophy in patients with Alzheimer disease (AD) in vivo. Thirty-two patients with moderate AD were divided into carriers and noncarriers of the epsilon 4 allele."

"These groups were matched for age, disease duration, education, and cognitive impairment. In all subjects, [C-11]PIB-PET was performed for measurement of cerebral A beta plaque deposition and cranial MRI for the assessment of gray matter volume by voxel-based morphometry (VBM) and for correction of partial volume effects (PVE) in the PET data....


Source: Genomics & Genetics Weekly (2009-06-19)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login